Intrinsic value of Enanta Pharmaceuticals, Inc. (ENTA)
Live fair value data for Enanta Pharmaceuticals, Inc. (ENTA) is currently unavailable. Please check again shortly.
Current Price: $66.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Enanta Pharmaceuticals, Inc. (ENTA) undervalued or overvalued?
Based on the current model output, Enanta Pharmaceuticals, Inc. appears to be undervalued with a upside of 54.00%.
Fair value vs market price — Enanta Pharmaceuticals, Inc. (ENTA)
Unlock premium access to view the live fair value comparison against current market price for ENTA.
Frequently Asked Questions - ENTA
How is ENTA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ENTA.
Is ENTA undervalued or overvalued right now?
ENTA is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ENTA: open their intrinsic value pages.